SKU	Name	Unit	Price	Delivery	QTY
SE067	Fumonisins monoclonal antibody	1mg	$667.6	10days
TA048	Fumonisins BSA antigen	1mg	$300	10days

SKU

Name

Unit

Price

Delivery

QTY

SE067

Fumonisins monoclonal antibody

1mg

$667.6

10days

TA048

Fumonisins BSA antigen

1mg

$300

10days

Description Operation References

AccuSift provides high‑performance fumonisin competitive assay pairings, characterized by exceptional batch‑to‑batch consistency and optimized for IVD kit development (Lateral Flow, Chemiluminescence, ELISA, POCT). These pairings offer high affinity and specificity, facilitating rapid detection.

Fumonisins are mycotoxins produced by Fusarium verticillioides. They are water‑soluble metabolites, consisting of structurally similar diester compounds formed from different polyhydric alcohols and tricarboxylic acids.

They primarily contaminate grains and their products, cause acute toxicity in some livestock, and exhibit potential carcinogenicity, making them a major research focus after aflatoxins.

On October 27, 2017, the World Health Organization’s International Agency for Research on Cancer (IARC) listed fumonisin B1, Fusarium verticillioidesand its produced toxins (fumonisin B1, fumonisin B2, and fusarin C) as Group 2B carcinogens in its preliminary compilation.

Performance Characteristics:

Sensitivity: ELISA IC50: 0.5 ppb; Colloidal Gold: 1 ppb
Cross‑Reactivity: FB1 100%; FB2 >80%; FB3 80%
Source: Mouse Monoclonal Antibody
Purity: ≥ 90%
Recommended Pairing: (Coating) / (Labeling)
Storage: Long‑term storage at ≤ –20°C; short‑term storage at 2–8°C. Shipped on ice packs.

Fumonisins Competitive Antibody Pair

Operation

References